Pulmonx Corporation LUNG
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 0.35% | 10.54% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.35% | 10.54% | |||
| Cost of Revenue | 8.42% | 10.39% | |||
| Gross Profit | -1.93% | 10.58% | |||
| SG&A Expenses | -7.99% | -9.69% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.68% | -5.15% | |||
| Operating Income | 17.30% | 30.09% | |||
| Income Before Tax | 17.13% | 26.35% | |||
| Income Tax Expenses | 13.53% | -10.74% | |||
| Earnings from Continuing Operations | 16.73% | 26.18% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 16.73% | 26.18% | |||
| EBIT | 17.30% | 30.09% | |||
| EBITDA | 18.79% | 31.17% | |||
| EPS Basic | 18.11% | 27.16% | |||
| Normalized Basic EPS | 18.51% | 27.34% | |||
| EPS Diluted | 18.11% | 27.16% | |||
| Normalized Diluted EPS | 18.51% | 27.34% | |||
| Average Basic Shares Outstanding | 1.67% | 1.36% | |||
| Average Diluted Shares Outstanding | 1.67% | 1.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||